Named as a key player in 33 of our reports, across 33 regions and countries.
2023–2033 CAGR · estimates
| Market | Category | World 2023 | CAGR |
|---|---|---|---|
| Gastrointestinal Drugs | Pharmaceuticals | $54 Bn | 4.6% |
Named as key players in the same markets as The Procter & Gamble Company (number of shared markets).
Bayer AG1 shared market
GlaxoSmithKline plc1 shared market
Pfizer Inc.1 shared market
PV Pharma Healthcare1 shared market
Roche India1 shared market
Sanofi1 shared market
SwisscheM Healthcare Pvt.Ltd1 shared market
Search all reports for The Procter & Gamble Company All companies